Cited by 34Renal Diseases and GlomerulopathiesChronic Kidney Disease and DiabetesLipid metabolism and disorders

Lipoprotein glomerulopathy: first case in a white European

Meyrier, A., Dairou, F., Callard, P., Mougenot, B.·1995·Nephrology Dialysis Transplantation

Abstract

Since 1988, 11 cases of a new entity, 'Lipoprotein glomerulopathy' (LG), were described in Japan. Some of these reports suggested that this glomerular lipid storage is due to excess apo E associated with heterozygous E2/3 apo E isoform. We report the first case of LG in a white European with no such lipid abnormalities. Proteinuria was discovered in 1967 when he was 42. Blood pressure and renal function were normal. Family history was negative. Renal biopsy disclosed lesions which were only understood at the time of the Japanese publications. They were composed of endocapillary glomerular deposits. Staining for lipids disclosed capillary loop obstruction with lipid droplets. Electron microscopy showed confluent droplets of various sizes obstructing capillary loops. Proteinuria progressively increased. In 1974 repeat renal biopsy showed the same lipid deposits, now associated with focal-segmental glomerulosclerosis (FSGS). Several serum lipoprotein and apolipoprotein studies ruled out any specific lipid derangement. This suggested a local glomerular disorder, presumably affecting the glomerular endocapillary disposal of lipids. A third biopsy showed progressive glomerular destruction by FSGS with persistence of the lipid droplets. Renal insufficiency progressed and haemodialysis was started in 1992. This observation suggests that LG is a local glomerular, not a general lipid disorder and indicates that this disease is not restricted to Asian patients.

Integrity signals

Registry

Crossref · 10.1093/ndt/10.4.546

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cited by

Sorted by citations

Authors
Meyrier, A., Dairou, F., Callard, P., & Mougenot, B.
Affiliations
  • Hôpital Avicenne (FR)
  • Pitié-Salpêtrière Hospital (FR)
  • Assistance Publique – Hôpitaux de Paris (FR)
Corresponding author
Meyrier, A.
Venue
Nephrology Dialysis Transplantation
Published
1995-04
Volume
10
Issue
4
Pages
546-549
ISSN
  • 0931-0509 (ISSN-L)
  • 1460-2385
OpenAlex
W2274640753
Cited by
34
References
0
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2022: 5 · 2019: 2 · 2014: 2 · 2013: 2
FWCI
2.14
Type
journal article
Language
en
Open access
closed
Locations
  • Nephrology Dialysis Transplantation (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords
lipoprotein glomerulopathy, focal segmental glomerulosclerosis, lipid droplets, proteinuria, apolipoprotein E, renal failure, hemodialysis
MeSH terms
Adult, Biopsy, Glomerulosclerosis, Focal Segmental, Humans, Lipidoses, Lipoproteins, Male, Microscopy, Electron, Proteinuria

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review